Lybrate.com has a number of highly qualified Oncologists in India. You will find Oncologists with more than 40 years of experience on Lybrate.com. You can find Oncologists online in Bangalore and from across India. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment
Submit a review for Dr. RudreshYour feedback matters!
I have a small cyst on both of my breast but it neither pains me firstly I do not know what is it but now this things pinch me out what is it? What should I do?
I am 24 year old suffring from prostatitis. Doctor give me 3 months of ofloxion400mg. And veltam0.4. After complete this treatment some issue are occure. I feel urine in my penics. Urine leecage some drop. Then doctor give me niftas 100mg for 3 months.
My father is 65 year old, he recently had an operation of prostrate gland, and after operation he daily get fever in the evening. please help on this.
I am 69 years of age, and suffer from osteo-arthritis of the knee and enlarged prostate. Please advise line of treatment. I had a spinal implant 2 years ago, am undergoing treatment for mild hypertension, but all other physical and bio-chemical parameters are normal.
Hello. My brother is suffering from toungh cancer which is exeeding thourgh his neck. He had a opertion of it. Recently we spoke to some doc. Some of which said we treat it with 70% of success (Dr. R k aggarwal- pitampura) we are realy very frustated. Pls someone let us know how many chances to suceseed. We wont going to second operation.
I am 65 years male from Kolkata suffering from DM type 2 from past 35 years, HTN, psychiatric problem from last 30 years, diagnosed with squamous cell carcinoma oral in 2011 undergone surgery, radiation, chemotherapy, at present carcinoma is in remission no abnormal uptake detected, having enlarged prostate from 2014 as per USG lower abdomen done it transpired as under: -urinary bladder normal in shape- walls are smooth and regular, lumen clear, pre void vol of urine- 330.2 ml post void vol of urine 295 approx of residual urine ,prostate gland measured 3.3×3.8×3.6 cm approx prostate wt 23.2 gms: -impression mildly enlarged prostate gland significant residual urine post void bladder (nearly same as pre void state) -PSA 1.3 ng/ml. On 17th instant repeated USG- whole abdomen: -all parameters normal, kidney right- 10. 9 cm left kidney 10.3.6 cm normal a cyst measure about 36 mm seen in left kidney (cyst was present before 2014 but those reports not found now unable to say the measurement of cyst) findings normal, post void residual urine vol 112 cc approx, prostate measures 35.8×30.9×32. 5 mm in size wt 20. 5mgm contour &ecotexer homogenous: -impression cortical seen in left kidney (present from long time, prostate gland size on higher side of the normal, post void residual urine 112 cc approx- PSA 6.16 ng/ml. Kindly give your opinion.
Brain metastases from systemic cancer are the most common type of intracranial neoplasm in adults, being almost 10 times more common than primary malignant brain tumors, which cause a significant burden on the management of patients with advanced cancer (1). The lungs represent one of the most frequent sources of metastases to the brain, with a probability of (36–64%) (3). Symptoms suffered by the patients include headaches, epilepsy, focal weakness, numbness or changes in mental status. The prognosis of patients with brain metastases is not optimistic and the median survival time is ∼1–2 months if left untreated. The 1-year survival rate has been recorded as 10.4% (4,5). The treatment of metastatic brain tumors is complex; not only due to being able to provide local control and improve neurological function, but also due to factors such as age, performance and systemic disease status and the size, volume, location and number of metastases at presentation
CyberKnife is a robotic radiosurgery system with a linear particle accelerator (linac), which is coupled with real-time imaging to track and compensate for the patient’s or target’s motion. As a relatively non-invasive treatment modality, CyberKnife demonstrates certain benefits, including a more accurate target localization and improved dose delivery for the management of metastatic brain tumors that allows higher biologically effective dose delivery without increased incidence of toxicity.
In the present case, the results for the treatment of multiple brain metastases after CyberKnife surgery with a 7–8 Gy marginal dose was promising. CyberKnife for metastatic brain tumors is an effective and safe method for reducing the marginal dose prescribed for multiple brain metastases and for minimizing the radiation-related neurotoxicities. In conclusion, CyberKnife, a focused, highly-targeted radiosurgery and fractionated radiotherapy is particularly useful for multiple brain metastases. CyberKnife provides the advantage of the management of local recurrence and a tolerable complication rate. Although the treatment of brain metastases has been performed with CyberKnife, the clinical significance and optimal dose fractionation scheme require further investigation.
In case you have a concern or query you can always consult an expert & get answers to your questions!